SEARCH

SEARCH BY CITATION

References

  • 1
    GotoM, MillerRW, eds. From Premature Gray Hair to Helicase – Werner Syndrome: Implications for Aging and Cancer. Tokyo: Scientific Societies Press & Karger, 2001.
  • 2
    Yu CE, Oshima J, Fu YH et al . Positional cloning of the Werner's syndrome gene. Science 1996; 272 (5259): 25862.
  • 3
    Shimamoto A, Sugimoto M, Furuichi Y. Molecular biology of Werner syndrome. Int J Clin Oncol 2004 Aug; 9 (4): 28898.
  • 4
    Yamabe Y, Shimamoto A, Goto M, Yokota J, Sugawara M, Furuichi Y. Sp1-mediated transcription of the Werner helicase gene is modulated by Rb and p53. Mol Cell Biol 1998; 18 (11): 6191200.
  • 5
    Goto M, Miller RW, Ishikawa Y, Sugano H. Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 1996; 5 (4): 23946.
  • 6
    Agrelo R, Cheng WH, Setien F et al . Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci USA 2006 (Jun 6); 103 (23): 88227.
  • 7
    Gebhart E, Bauer R, Raub U, Schinzel M, Ruprecht KW, Jonas JB. Spontaneous and induced chromosomal instability in Werner syndrome. Hum Genet 1988; 80 (2): 1359.
  • 8
    Okada M, Goto M, Furuichi Y, Sugimoto M. Differential effects of cytotoxic drugs on mortal and immortalized B-lymphoblastoid cell lines from normal and Werner's syndrome patients. Biol Pharm Bull 1998; 21 (3): 2359.
  • 9
    Harley CB, Kim NW, Prowse KR et al . Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994; 59: 30715.
  • 10
    Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994; 68 (5): 341014.
  • 11
    Sugimoto M, Furuichi Y, Goto M, Tahara H, Ide T. Senecence, immortalization and tumorigenesis of B-lymphoblastoid cell lines established by transformation with Epstein-Barr virus: disproof of the commonly-held view. In: UmarCS, ed. New Developments in Epstein-Barr Virus Research. New York: Nova Science publishers, Inc., 2006.
  • 12
    Sugimoto M, Tahara H, Ide T, Furuichi Y. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 2004 (May 15); 64 (10): 33614.
  • 13
    Sugimoto M, Ide T, Goto M, Furuichi Y. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech Ageing Dev 1999; 107 (1): 5160.
  • 14
    Sugimoto M, Ide T, Goto M, Furuichi Y. Incorrect use of ‘immortalization’ for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J Virol 1999; 73: 96901.
  • 15
    Sugimoto M, Tahara H, Okubo M et al . WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet Cytogenet 2004 (Jul 15); 152 (2): 95100.
  • 16
    Takahashi T, Kawabe T, Okazaki Y et al . In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. DNA Cell Biol 2003 Nov; 22 (11): 72735.
  • 17
    Goto M, Ishikawa Y. [Werner syndrome]. Nippon Rinsho 2000 Jul; 58 (7): 14905 (In Japanese.)
  • 18
    Artandi SE, DePinho RA. A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 2000 Feb; 10 (1): 3946.
  • 19
    Tahara H, Tokutake Y, Maeda S et al . Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus. Oncogene 1997; 15 (16): 191120.
  • 20
    Yamagata K, Kato J, Shimamoto A, Goto M, Furuichi Y, Ikeda H. Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc Natl Acad Sci USA 1998; 95 (15): 87338.
  • 21
    Sharpless NE, DePinho RA. Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004 Jan; 113 (2): 1608.
  • 22
    Greenberg RA. Telomeres, crisis and cancer. Curr Mol Med 2005 Mar; 5 (2): 21318.
  • 23
    Kawabe T, Tsuyama N, Kitao S et al . Differential regulation of human RecQ family helicases in cell transformation and cell cycle [In Process Citation]. Oncogene 2000; 19 (41): 476472.
  • 24
    Shiratori M, Sakamoto S, Suzuki N et al . Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J Cell Biol 1999; 144 (1): 19.
  • 25
    Sawada K, Noda K, Nakajima H, Shimbara N, Furuichi Y, Sugimoto M. Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines. Biol Pharm Bull 2005 July; 28 (7): 12027.
  • 26
    Poot M, Gollahon KA, Rabinovitch PS. Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum Genet 1999 Jan; 104 (1): 1014.
  • 27
    Lebel M, Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc Natl Acad Sci USA 1998; 95 (22): 13 097102.
  • 28
    Elli R, Chessa L, Antonelli A, Petrinelli P, Ambra R, Marcucci L. Effects of topoisomerase II inhibition in lymphoblasts from patients with progeroid and ‘chromosome instability’ syndromes. Cancer Genet Cytogenet 1996 Apr; 87 (2): 11216.
  • 29
    Futami K, Takagi M, Shimamoto A, Sugimoto M, Furuichi Y. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase. Biol Pharm Bull 2007; 30 (10): 195861.
  • 30
    Marciniak RA, Lombard DB, Johnson FB, Guarente L. Nucleolar localization of the Werner syndrome protein in human cells. Proc Natl Acad Sci USA 1998; 95 (12): 688792.
  • 31
    Sakamoto S, Nishikawa K, Heo SJ, Goto M, Furuichi Y, Shimamoto A. Werner helicase relocates into nuclear foci in response to DNA damaging agents and co-localizes with RPA and Rad51. Genes Cells 2001; 6 (5): 42130.
  • 32
    Brosh RM Jr, Orren DK, Nehlin JO, Ravn PH, Kenny MK, Machwe A et al . Functional and physical interaction between WRN helicase and human replication protein A. J Biol Chem 1999 (Jun 25); 274 (26): 1834150.
  • 33
    Martin GM. A brief history of research on the Werner syndrome. In: GotoM, MillerRW, eds. From Premature Gray Hair to Helicase – Werner Syndrome: Implications for Aging and Cancer. Tokyo: Science Societies Press & Kagrer, 2001.
  • 34
    Schulz VP, Zakian VA, Ogburn CE et al . Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 1996; 97 (6): 7504.
  • 35
    Griffith JD, Comeau L, Rosenfield S et al . Mammalian telomeres end in a large duplex loop. Cell 1999; 97 (4): 50314.
  • 36
    Greider CW. Telomeres do d-loop-T-loop [comment]. Cell 1999; 97 (4): 41922.
  • 37
    Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 1997; 6 (6): 9216.
  • 38
    Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. Embo J 1995; 14 (17): 42408.
  • 39
    Li B, Comai L. Functional interaction between Ku and the werner syndrome protein in DNA end processing. J Biol Chem 2000; 275 (37): 28 34952.
  • 40
    Cooper MP, Machwe A, Orren DK, Brosh RM, Ramsden D, Bohr VA. Ku complex interacts with and stimulates the Werner protein. Genes Dev 2000; 14 (8): 90712.
  • 41
    Pichierri P, Rosselli F, Franchitto A. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle. Oncogene 2003 (Mar 13); 22 (10): 1491500.
  • 42
    Blander G, Zalle N, Daniely Y, Taplick J, Gray MD, Oren M. DNA damage-induced translocation of the Werner helicase is regulated by acetylation. J Biol Chem 2002 (Dec 27); 277 (52): 50 93440.
  • 43
    Brosh RM Jr, Von Kobbe C, Sommers JA et al . Werner syndrome protein interacts with human flap endonuclease 1 and stimulates its cleavage activity. Embo J 2001 (Oct 15); 20 (20): 5791801.
  • 44
    Cheng WH, Von Kobbe C, Opresko PL et al . Werner syndrome protein phosphorylation by abl tyrosine kinase regulates its activity and distribution. Mol Cell Biol 2003 Sept; 23 (18): 638595.
  • 45
    Lebel M, Spillare EA, Harris CC, Leder P. The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J Biol Chem 1999 (Dec 31); 274 (53): 37 7959.
  • 46
    Kamath-Loeb AS, Loeb LA, Johansson E, Burgers PM, Fry M. Interactions between the Werner syndrome helicase and DNA polymerase delta specifically facilitate copying of tetraplex and hairpin structures of the d (CGG) n trinucleotide repeat sequence. J Biol Chem 2001 (May 11); 276 (19): 16 43946.
  • 47
    Weinstein IB. Cancer. Addiction to oncogenes – the Achilles heal of cancer. Science 2002 (Jul 5); 297 (5578): 634.
  • 48
    Sharma SV, Gajowniczek P, Way IP et al . A common signaling cascade may underlie ‘addiction’ to the Src, BCR-ABL, and EGF receptor oncogenes. Cancer Cell 2006 Nov; 10 (5): 42535.